Ascletis Pharma Inc. (ASCLF)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.41 Million CNY | 98.63% |
| 2022 | 4.23 Million CNY | 54.07% |
| 2021 | 2.75 Million CNY | 73.28% |
| 2020 | 1.58 Million CNY | -58.38% |
| 2019 | 3.81 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - CNY | -100.0% |
| 2024 Q2 | - CNY | 0.0% |
| 2023 Q2 | 3.03 Million CNY | 160.19% |
| 2023 Q1 | 1.16 Million CNY | -72.43% |
| 2023 FY | 8.41 Million CNY | 98.63% |
| 2023 Q4 | 8.41 Million CNY | 211.01% |
| 2023 Q3 | 2.7 Million CNY | -10.96% |
| 2022 Q2 | 1.75 Million CNY | 192.64% |
| 2022 FY | 4.23 Million CNY | 54.07% |
| 2022 Q1 | 598 Thousand CNY | -78.25% |
| 2022 Q4 | 4.23 Million CNY | 132.67% |
| 2022 Q3 | 1.82 Million CNY | 4.06% |
| 2021 FY | 2.75 Million CNY | 73.28% |
| 2021 Q3 | 1.18 Million CNY | -69.46% |
| 2021 Q4 | 2.75 Million CNY | 132.66% |
| 2021 Q1 | 1.74 Million CNY | 10.21% |
| 2021 Q2 | 3.87 Million CNY | 121.27% |
| 2020 Q2 | 2.68 Million CNY | 163.11% |
| 2020 Q3 | 443 Thousand CNY | -83.53% |
| 2020 Q4 | 1.58 Million CNY | 258.24% |
| 2020 FY | 1.58 Million CNY | -58.38% |
| 2020 Q1 | 1.02 Million CNY | -73.2% |
| 2019 Q2 | 5.52 Million CNY | 56.64% |
| 2019 FY | 3.81 Million CNY | 0.0% |
| 2019 Q4 | 3.81 Million CNY | 140.26% |
| 2019 Q3 | 1.58 Million CNY | -71.25% |
| 2019 Q1 | 3.52 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 79.574% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -104.175% |
| SQZ Biotechnologies Company | 27.47 Million USD | 69.364% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 80.596% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 71.727% |
| Mesoblast Limited | 118.7 Million USD | 92.91% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -787.51% |
| Genus plc | 233.1 Million USD | 96.39% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -187.197% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -526.384% |
| Marizyme, Inc. | 18.71 Million USD | 55.037% |
| ContraFect Corporation | 2.88 Million USD | -192.121% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -1022.133% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -6111.666% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -481.891% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -261.83% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -48.736% |
| MultiCell Technologies, Inc. | 202.58 USD | -4154308.135% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 85.361% |
| EV Biologics, Inc. | 1.49 Million USD | -463.037% |
| Q BioMed Inc. | 4.1 Million USD | -104.77% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 74.575% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -1235.71% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -585.141% |
| Biomind Labs Inc. | 735.54 Thousand USD | -1044.19% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 95.094% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 35.247% |
| Skye Bioscience, Inc. | 4.61 Million USD | -82.351% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -847.679% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -5846.947% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -43.346% |
| IMV Inc. | 28.88 Million USD | 70.863% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -32622.89% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -272.656% |
| GB Sciences, Inc. | 1.75 Million USD | -378.37% |
| Alpha Cognition Inc. | 1.22 Million USD | -589.626% |
| HST Global, Inc. | 98.31 Thousand USD | -8459.892% |
| CSL Limited | 12.18 Billion USD | 99.931% |
| Halberd Corporation | 150 Thousand USD | -5510.667% |
| Enzolytics Inc. | 996.33 Thousand USD | -744.693% |
| Resverlogix Corp. | 6.49 Million USD | -29.656% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -1662.513% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -3192.748% |
| argenx SE | 20 Million USD | 57.92% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 81.528% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -210.702% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -82208.068% |
| Genscript Biotech Corporation | 417.73 Million USD | 97.985% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -4095.079% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -251.0% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -3570.445% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 87.558% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -178.105% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -2239.663% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 58.599% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -5561.469% |
| BioStem Technologies, Inc. | 4.71 Million USD | -78.63% |
| ONE Bio Corp. | 19.71 Million USD | 57.312% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -3263.951% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -3283.725% |
| Agentix Corp. | 50 Thousand USD | -16732.0% |
| LadRx Corporation | 33.6 Thousand USD | -24943.147% |
| Cell Source, Inc. | 9.25 Million USD | 9.057% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -1012.927% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -1012.927% |
| NovAccess Global Inc. | 2.19 Million USD | -282.566% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -18.991% |
| Itoco Inc. | 228.37 Thousand USD | -3585.135% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -3889.098% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -68.894% |
| Kadimastem Ltd | 891.22 Thousand USD | -844.317% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -1994.319% |
| CytoDyn Inc. | 30.07 Million USD | 72.018% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -1637.823% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -2291.949% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -7.622% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -6770.204% |
| Rebus Holdings, Inc. | 310 Thousand USD | -2614.839% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -77.73% |
| International Stem Cell Corporation | 4.17 Million USD | -101.436% |
| Bioxytran, Inc. | 1.92 Million USD | -337.195% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -13384.37% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -285.896% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -1.203% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 1.969% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -441.055% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -3040.299% |
| Neutra Corp. | 54.15 Thousand USD | -15440.291% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -359.891% |
| PureTech Health plc | 25.51 Million USD | 67.012% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -587.455% |
| IXICO plc | 472.02 Thousand USD | -1682.964% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 45.707% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 86.483% |
| CSL Limited | 12.18 Billion USD | 99.931% |
| Cellectis S.A. | 92.77 Million USD | 90.929% |